Alpha MSH: A Key Neuropeptide in Pigmentation, Metabolism, and Inflammation
Endocrinology Diagnostics
Structure and Biosynthesis
- Alpha-melanocyte stimulation hormone (α-MSH) is a 13 amino acid peptide hormone derived from pro-opiomelanocortin (POMC).
- Primarily produced in the pituitary gland's intermediate lobe, and also found in the hypothalamus and skin cells.
- Conversion of POMC involves pro-hormone converting enzymes to form alpha-MSH.
- The mature peptide includes the sequence His-Phe-Arg-Trp, crucial for its biological functions and binding to receptors.
- Post-translational modifications like acetylation and amidation are essential for hormone activity.
Physiological Functions and Receptor Interactions
- Works by interacting with melanocortin receptors (MCRs), particularly MC1R, MC3R, and MC4R.
- By binding to MC1R in melanocytes, α-MSH increases melanin production and distribution, essential for skin coloration and sun protection.
- In the hypothalamus, interaction with MC3R and MC4R regulates energy balance, hunger levels, and metabolic rate.
- Acts as a signal for suppressing appetite, leading to reduced food consumption and increased energy usage.
- Exhibits anti-inflammatory characteristics by inhibiting inflammatory cytokine production and encouraging anti-inflammatory agents.
Role in Disease and Pathological Conditions
- Irregularities in α-MSH signaling linked to health issues:
- Skin pigmentation problems, such as albinism or excessive pigmentation.
- Weight-related and metabolic disorders, often due to mutations or malfunctions in MC4R.
- Inflammatory diseases like: inflammatory bowel disease, arthritis, and multiple sclerosis.
- Specific forms of skin cancers, like melanoma, indicating its role in disease progression and treatment possibilities.
Therapeutic Applications and Clinical Development
- Generated interest for treatment purposes due to its various functions.
- Synthetic versions like afamelanotide (Scenesse®) approved for managing protoporphyria and light sensitivity issues.
- Research ongoing for treatments based on α-MSH for obesity and metabolic disorders, with some MC4R receptor agonists showing promising results.
- Innovative methods for delivering medications and adjusting peptide derivatives address issues like effectiveness and duration in the body.
Suitable ELISA Kits
Visit the BioSupply Ltd website for more information on Alpha MSH: A Key Neuropeptide in Pigmentation, Metabolism, and Inflammation